Libya vs Morocco: Share of pregnant women with HIV that receive antiretroviral therapy
Libya
70.0%
in 2023
Morocco
72.0%
in 2024
Libya rank
51st
Morocco rank
49th
Share of pregnant women with HIV that receive antiretroviral therapy over time
- Libya
- Morocco
How they compare
Morocco currently reports 72.0% against 70.0% in Libya, a difference of 2.0%.
The two have swapped places 1 time across 18 shared years of data; in 2000 it was Morocco ahead.
Libya ranks 51st and Morocco ranks 49th of 84 countries.
Across the 3 decades both report, Libya averaged higher in 2 and Morocco in 1.
Head to head by decade
| Decade | Libya | Morocco | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 3.9% | 3.9% | Morocco |
| 2010s | 65.8% | 43.5% | 22.2% | Libya |
| 2020s | 71.0% | 51.8% | 19.2% | Libya |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of pregnant women with hiv that receive antiretroviral therapy, Libya or Morocco?
- Morocco, at 72.0% against 70.0% in Libya as of 2024.
- What is the difference in share of pregnant women with hiv that receive antiretroviral therapy between Libya and Morocco?
- 2.0%, with Morocco ahead.
- How many years of comparable data are there for Libya and Morocco?
- 18 years are reported by both, from 2000 to 2023.
- How do Libya and Morocco rank globally for share of pregnant women with hiv that receive antiretroviral therapy?
- Libya ranks 51st and Morocco ranks 49th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of pregnant women with HIV that receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral medicine is used to prevent mother-to-child transmission of HIV.